Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
2.

Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2018 May - Jun;8(3):e185-e186. doi: 10.1016/j.prro.2017.08.002. Epub 2017 Aug 5. No abstract available.

PMID:
29724403
3.

The risk of carotid stenosis in head and neck cancer patients after radiation therapy.

Carpenter DJ, Mowery YM, Broadwater G, Rodrigues A, Wisdom AJ, Dorth JA, Patel PR, Shortell CK, Clough R, Brizel DM.

Oral Oncol. 2018 May;80:9-15. doi: 10.1016/j.oraloncology.2018.02.021. Epub 2018 Mar 14.

PMID:
29706194
4.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
5.

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):246-253. doi: 10.1016/j.prro.2017.02.002. Epub 2017 Apr 17.

PMID:
28428019
6.

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S.

Cancer. 2017 Apr 1;123(7):1259-1271. doi: 10.1002/cncr.30449. Epub 2016 Dec 1.

7.

Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.

Hu F, Vishwanath K, Salama JK, Erkanli A, Peterson B, Oleson JR, Lee WT, Brizel DM, Ramanujam N, Dewhirst MW.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):462-469. doi: 10.1016/j.ijrobp.2016.06.007. Epub 2016 Jun 14.

8.

Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer.

Hashemi-Sadraei N, Sikora AG, Brizel DM.

Am Soc Clin Oncol Educ Book. 2016;35:e277-82. doi: 10.14694/EDBK_157801. Review.

9.

Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.

Pollom EL, Song J, Durkee BY, Aggarwal S, Bui T, von Eyben R, Li R, Brizel DM, Loo BW, Le QT, Hara WY.

Head Neck. 2016 Oct;38(10):1472-8. doi: 10.1002/hed.24454. Epub 2016 Apr 4.

PMID:
27043927
10.

Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.

Ashcraft KA, Boss MK, Tovmasyan A, Roy Choudhury K, Fontanella AN, Young KH, Palmer GM, Birer SR, Landon CD, Park W, Das SK, Weitner T, Sheng H, Warner DS, Brizel DM, Spasojevic I, Batinic-Haberle I, Dewhirst MW.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):892-900. doi: 10.1016/j.ijrobp.2015.07.2283. Epub 2015 Jul 29.

11.

Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans.

Schmidt M, Lo JY, Grzetic S, Lutzky C, Brizel DM, Das SK.

Med Phys. 2015 Aug;42(8):4428-34. doi: 10.1118/1.4923174.

PMID:
26233173
12.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

13.

Different strokes for different folks: new paradigms for staging oropharynx cancer.

Brizel DM.

J Clin Oncol. 2015 Mar 10;33(8):817-8. doi: 10.1200/JCO.2014.60.1757. Epub 2015 Feb 9. No abstract available.

PMID:
25667276
14.

Current status of clinical trials in head and neck cancer 2014.

Liu JC, Ridge JA, Brizel DM, O'Sullivan B, Cohen EW, Mann BS, Adelstein DJ.

Otolaryngol Head Neck Surg. 2015 Mar;152(3):410-7. doi: 10.1177/0194599814566595. Epub 2015 Jan 20. Review.

PMID:
25605695
15.

Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.

Hoang JK, Choudhury KR, Chang J, Craciunescu OI, Yoo DS, Brizel DM.

AJR Am J Roentgenol. 2014 Nov;203(5):1104-8. doi: 10.2214/AJR.14.12838.

PMID:
25341151
16.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

17.

Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer.

Rao NG, Trotti A, Kim J, Schell MJ, Zhao X, Amdur RJ, Brizel DM, Chambers MS, Caudell JJ, Miyamoto C, Rosenthal DI.

Oral Oncol. 2014 Aug;50(8):765-9. doi: 10.1016/j.oraloncology.2014.06.001. Epub 2014 Jun 20.

18.

Comprehensive population-averaged arterial input function for dynamic contrast-enhanced vmagnetic resonance imaging of head and neck cancer.

Onxley JD, Yoo DS, Muradyan N, MacFall JR, Brizel DM, Craciunescu OI.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):658-65. doi: 10.1016/j.ijrobp.2014.03.006.

PMID:
24929169
19.

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. Erratum in: J Natl Compr Canc Netw. 2013 Dec 1;11(12):1458.

PMID:
23946171
20.

Contemporary radiotherapy in head and neck cancer: balancing chance for cure with risk for complication.

Cabrera AR, Yoo DS, Brizel DM.

Surg Oncol Clin N Am. 2013 Jul;22(3):579-98. doi: 10.1016/j.soc.2013.02.001. Epub 2013 Mar 14. Review.

PMID:
23622081
21.

Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy.

Dorth JA, Patel PR, Broadwater G, Brizel DM.

Head Neck. 2014 Feb;36(2):215-9. doi: 10.1002/hed.23280. Epub 2013 Apr 2.

22.

Radiation induces aerobic glycolysis through reactive oxygen species.

Zhong J, Rajaram N, Brizel DM, Frees AE, Ramanujam N, Batinic-Haberle I, Dewhirst MW.

Radiother Oncol. 2013 Mar;106(3):390-6. doi: 10.1016/j.radonc.2013.02.013. Epub 2013 Mar 28.

23.

Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.

Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, Genden EM, Beitler JJ, Weinstein GS, Quon H, Chepeha DB, Ferris RL, Weber RS, Movsas B, Waldron J, Lowe V, Ramsey S, Manola J, Yueh B, Carey TE, Bekelman JE, Konski AA, Moore E, Forastiere A, Schuller DE, Lynn J, Ullmann CD.

Head Neck. 2012 Dec;34(12):1681-703. doi: 10.1002/hed.23136. Epub 2012 Sep 26.

24.

Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.

Quon H, Brizel DM.

Semin Radiat Oncol. 2012 Jul;22(3):220-32. doi: 10.1016/j.semradonc.2012.03.007. Review.

PMID:
22687947
25.

Mucosal melanoma of the head and neck.

Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Mar;10(3):320-38. No abstract available.

PMID:
22393194
26.

Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer.

Yoo DS, Kirkpatrick JP, Craciunescu O, Broadwater G, Peterson BL, Carroll MD, Clough R, MacFall JR, Hoang J, Scher RL, Esclamado RM, Dunphy FR, Ready NE, Brizel DM.

Clin Cancer Res. 2012 Mar 1;18(5):1404-14. doi: 10.1158/1078-0432.CCR-11-1982. Epub 2012 Jan 17.

27.

Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.

Craciunescu OI, Yoo DS, Cleland E, Muradyan N, Carroll MD, MacFall JR, Barboriak DP, Brizel DM.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e345-50. doi: 10.1016/j.ijrobp.2011.05.059. Epub 2011 Oct 8.

PMID:
21985945
28.

Controversies in the locoregional management of head and neck cancer.

Brizel DM, Lydiatt W, Colevas AD.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):653-62. Review.

PMID:
21636537
29.

Head and neck cancers.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. Review. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Jul;9(7):xxxiii.

PMID:
21636536
30.

Head and neck cancer as a model for advances in imaging prognosis, early assessment, and posttherapy evaluation.

Brizel DM.

Cancer J. 2011 May-Jun;17(3):159-65. doi: 10.1097/PPO.0b013e31821e8a09. Review.

PMID:
21610469
31.

Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.

Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, Langendijk JA, Komaki R, Swan Leong S, Levendag P, Pignon JP.

J Clin Oncol. 2011 Jun 20;29(18):2590-7. doi: 10.1200/JCO.2010.33.1454. Epub 2011 May 16.

PMID:
21576630
32.

Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map.

Ren L, Chetty IJ, Zhang J, Jin JY, Wu QJ, Yan H, Brizel DM, Lee WR, Movsas B, Yin FF.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1584-93. doi: 10.1016/j.ijrobp.2011.02.002. Epub 2011 Apr 7.

PMID:
21477945
33.

Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.

Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53. doi: 10.1016/j.ijrobp.2010.11.050. Epub 2011 Jan 27.

PMID:
21277108
34.

The role of adaptive and functional imaging modalities in radiation therapy: approach and application from a radiation oncology perspective.

Yoo DS, Wong TZ, Brizel DM.

Semin Ultrasound CT MR. 2010 Dec;31(6):444-61. doi: 10.1053/j.sult.2010.10.002. Review.

PMID:
21147372
35.

FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.

Roach MC, Turkington TG, Higgins KA, Hawk TC, Hoang JK, Brizel DM.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):321-6. doi: 10.1016/j.ijrobp.2010.08.055. Epub 2010 Oct 27.

PMID:
21030160
36.

Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.

Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, Meredith RF, Epstein JB, Le QT, Brizel DM, Bellm LA, Wells N, Cella D.

J Pain Symptom Manage. 2009 Oct;38(4):522-32. doi: 10.1016/j.jpainsymman.2008.12.004. Epub 2009 Jul 15.

PMID:
19608377
37.

Paraganglioma of the head and neck: long-term local control with radiotherapy.

Chino JP, Sampson JH, Tucci DL, Brizel DM, Kirkpatrick JP.

Am J Clin Oncol. 2009 Jun;32(3):304-7. doi: 10.1097/COC.0b013e318187dd94.

PMID:
19433962
38.

Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.

Salama JK, Haddad RI, Kies MS, Busse PM, Dong L, Brizel DM, Eisbruch A, Tishler RB, Trotti AM, Garden AS.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):725-33. doi: 10.1016/j.ijrobp.2008.11.059. Epub 2009 Apr 11.

PMID:
19362781
39.

Targeting the future in head and neck cancer.

Brizel DM.

Lancet Oncol. 2009 Mar;10(3):204-5. doi: 10.1016/S1470-2045(09)70051-8. No abstract available.

PMID:
19261251
40.

Induction chemotherapy: to use or not to use? That is the question.

Brizel DM, Vokes EE.

Semin Radiat Oncol. 2009 Jan;19(1):11-6. doi: 10.1016/j.semradonc.2008.09.003. Review.

PMID:
19028340
41.

Head and neck cancer. Introduction.

Brizel DM.

Semin Radiat Oncol. 2009 Jan;19(1):1-2. doi: 10.1016/j.semradonc.2008.09.001. No abstract available.

PMID:
19028338
42.

Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.

Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W.

J Clin Oncol. 2008 May 20;26(15):2489-96. doi: 10.1200/JCO.2007.13.7349.

PMID:
18487568
43.

On-board patient positioning for head-and-neck IMRT: comparing digital tomosynthesis to kilovoltage radiography and cone-beam computed tomography.

Wu QJ, Godfrey DJ, Wang Z, Zhang J, Zhou S, Yoo S, Brizel DM, Yin FF.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):598-606.

PMID:
17869673
44.

Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.

Vujaskovic Z, Thrasher BA, Jackson IL, Brizel MB, Brizel DM.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):534-40.

PMID:
17869666
45.

Pharmacologic approaches to radiation protection.

Brizel DM.

J Clin Oncol. 2007 Sep 10;25(26):4084-9. Review.

PMID:
17827457
46.

Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.

Koontz BF, Miles EF, Rubio MA, Madden JF, Fisher SR, Scher RL, Brizel DM.

Head Neck. 2008 Feb;30(2):262-6.

PMID:
17685450
47.

How much radiation is the chemotherapy worth in advanced head and neck cancer?

Kasibhatla M, Kirkpatrick JP, Brizel DM.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1491-5.

PMID:
17674979
48.

The potential role of intrinsic hypoxia markers as prognostic variables in cancer.

Moon EJ, Brizel DM, Chi JT, Dewhirst MW.

Antioxid Redox Signal. 2007 Aug;9(8):1237-94. Review.

PMID:
17571959
49.

Multiple etiologies of tumor hypoxia require multifaceted solutions.

Dewhirst MW, Navia IC, Brizel DM, Willett C, Secomb TW.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):375-7. No abstract available.

50.

A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.

Anné PR, Machtay M, Rosenthal DI, Brizel DM, Morrison WH, Irwin DH, Chougule PB, Estopinal NC, Berson A, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):445-52. Epub 2006 Dec 4.

PMID:
17141978

Supplemental Content

Loading ...
Support Center